Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

---
identifier: "/us/fr/2015-13316"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review"
title_number: 0
title_name: "Federal Register"
section_number: "2015-13316"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review"
positive_law: false
currency: "2015-06-02"
last_updated: "2015-06-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2015-13316"
document_type: "notice"
publication_date: "2015-06-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "80 FR 31381"
fr_volume: 80
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to PA 07-318, NIOSH Member Conflict Review.

*Time and date:* 1:00 p.m.-4:00 p.m., EST, June 25, 2015 (Closed)

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters for discussion:* The meeting will include the initial review, discussion, and evaluation of applications received in response to “NIOSH Member Conflict PA 07-318.”

*Contact person for more information:* Nina Turner, Ph.D., Scientific Review  Officer, NIOSH, CDC, 1095 Willowdale Road, Mailstop G800, Morgantown, West Virginia 26506, Telephone: (304) 285-5976.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.